AC Immune (ACIU) Accumulated Depreciation (2016 - 2017)
AC Immune's (ACIU) quarterly Accumulated Depreciation came in at -$2.7 million in Q3 2017, down 23.22% on a QoQ basis from -$2.2 million in Q4 2016.
AC Immune (ACIU) Accumulated Depreciation (2016 - 2017) Analysis & Trends
AC Immune (ACIU) has 2 years of Accumulated Depreciation data on file, last reported at -$2.7 million in Q3 2017.
- On a quarterly basis, Accumulated Depreciation changed N/A year-over-year to -$2.7 million in Q3 2017; TTM through Sep 2017 was -$2.7 million, a N/A change from a year earlier, with the FY2016 full-year figure at -$2.2 million, changed N/A from the prior year.
- Accumulated Depreciation for Q3 2017 stood at -$2.7 million, down from -$2.2 million in the prior quarter.
- Over the last five years, Accumulated Depreciation for ACIU reached as high as -$2.2 million in Q4 2016 and fell as low as -$2.7 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -2.66 Mn |
| Dec 31, 2016 | -2.16 Mn |